AI News
 Malaffi Events: AH 2023 at Philips- Dr Sanji de Silva, VP of Clinical Engagement and Informatics
Malaffi - (Tuesday February 14, 2023) …  GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’
MedCity News - (Tuesday February 14, 2023) Vir Biotechnology’s Covid-19 research may yield more drugs and perhaps a vaccine, but no longer with the financial support of GSK. The collaboration agreement the two companies struck up in the early days of the pandemic has been amended, leaving Vir to either find another partner or continue its coronavirus research on its own. |
 Automated Feeding Platform to Study Mosquito Disease Transmission
Medgadget - (Tuesday February 14, 2023) A team at Rice University has developed an automated feeding platform for mosquitoes that allows researchers to test different types of repellent and investigate mosquito-borne disease transmission. Traditionally, such mosquito research would require human volunteers or animal subjects for the mosquitos to feed on, but this is obviously inconvenient and a little distasteful. This new system dispenses with the need for human volunteers and associated laborious data collection and analysis. The technology consists of 3D printed synthetic skin with real blood that flows through small vessels. Mosquitos can feed through the skin and are kept in place in a surrounding […]…  Federal agencies offer updates on TEFCA, interoperability milestones
Healthcare IT news - (Tuesday February 14, 2023) On February 13, the government leaders thanked the Office of the National Coordinator for Health IT and six Qualified Health Information Networks (QHIN) for working to create a nationwide interoperability network under the 21st Century Cures Act. The ‘Network of Networks’ |
 Electrochemical Sensor for Detailed SARS-CoV-2 Immunity Data
Medgadget - (Tuesday February 14, 2023) Researchers at the Harvard Wyss Institute have developed an electrochemical device, called the eRapid sensor, that can assist clinicians in quickly characterizing someone’s COVID-19 infection, including identifying the infecting viral variant and the nature of someone’s immunity to the virus in terms of whether it is vaccine-mediated or natural immunity. Monitoring these characteristics could help to personalize treatment for individuals and also provide data for drug development and inform government decisions on the best way to manage COVID-19 in the community. When antibodies from a blood sample bind within the device, it precipitates a biochemical cascade that affects the electrical […]…  Nanowire Assay Detects Brain Tumors from Urine
Medgadget - (Tuesday February 14, 2023) Researchers at Nagoya University in Japan have developed a nanowire assay that can be used to capture and detect specific extracellular vesicles in a urine sample that indicate the presence of a brain tumor. These extracellular vesicles are naturally excreted in the urine but techniques to capture and analyze them have been complex, requiring different pieces of equipment, until now. This all-in-one assay uses a simple well plate that has been coated with zinc oxide nanowires that extracellular vesicles are attracted to because of their surface electrical charge. Then, the researchers can detect tumor-specific extracellular vesicles in each well using […]… |
 Epic, eHealth Exchange and CommonWell among HHS-approved QHIN candidates
Healthcare IT news - (Tuesday February 14, 2023) A half-dozen organizations on Monday were approved by the Department of Health and Human Services as the inaugural batch of candidates to participate as qualified health information networks as part of ONC’s Trusted Exchange Framework and Common Agreement.During a Feb. 13 event at the U.S. Department of Health and Human Services, six healthcare organizations were approved to implement TEFCA as prospective QHINs: CommonWell Health Alliance, eHealth Exchange, Epic TEFCA Interoperability Services, Health Gorilla, Kno2, and KONZA National Network.  Malaffi Events: Arab Health 2023 at Philips- Dr. Nasser Al Riyami, COO of Burjeel Medical City
Malaffi - (Tuesday February 14, 2023) … |
 95% of Certified Health IT Developers Met ONC Cures Act Deadline
DistilINFO Hospital IT - (Tuesday February 14, 2023) – More than 95 percent of certified health IT developers met the Cures Act Final Rule compliance deadline to provide customers with new technology, according to an ONC HealthITBuzz blog post. The Cures Act Final Rule mandated many changes to the Certification Program, including four updates set to have long-lasting interoperability impacts on patients, clinicians, and developers. ONC Certified Health IT developers must: Advance interoperability for patients and providers through the use of FHIR-based application programming interfaces (APIs);Enable patients, providers, and other stakeholders to have access to consistent data elements represented in at least version one of the United States Core…  How Mental Healthcare Access can Improve to Meet Patient Needs
DistilINFO Hospital IT - (Tuesday February 14, 2023) – Meeting patient needs for mental healthcare access will require industry leaders, clinicians, and healthcare policymakers to focus on giving clinicians the tools needed to meet patients in any care setting, as well as enable more ample access to mental healthcare providers, according to a new paper from the Alliance for Patient Access (AfPA). More patients than ever are seeking mental healthcare, with AfPA citing figures that 53 million Americans now live with some kind of mental illness. Exacerbated by the COVID-19 pandemic, this prevalence of mental illness has pushed the mental health space to face unheard-of patient demand. But patients… |
